A large-scale analysis has revealed independently validated gut biomarkers that can distinguish patients with inflammatory ...

Scientists at the Icahn School of Medicine at Mount Sinai have uncovered a surprising genetic connection between two very ...

Factors linked to C difficile infection in patients with IBD include IBD activity prior to infection, shorter disease ...

Up to 40% of patients with inflammatory bowel disease (IBD) experience extraintestinal manifestations (EIMs), with the ...

Ensho Therapeutics has presented additional data supporting NSHO-101, also referred to as EA1080, as an oral one-time-a-day ...

Eli Lilly (Lilly) has agreed to make a $10m upfront payment for full worldwide rights to San Diego-based Organovo Holdings’ ...

For more than a decade, Michelle Hobson endured extreme fatigue, excruciating abdominal pain, and repeated hospital visits.

Major Cause of Inflammatory Bowel Disease Discovered June 5, 2024 — Researchers have discovered a new biological pathway that is a principal driver of inflammatory bowel disease (IBD ...

Switching back from infliximab biosimilar SB2 to reference infliximab (Remicade) did not affect clinical disease activity or ...

A team of international researchers, led by scientists from the University of Toronto, has discovered a compound in ginger ...

A ginger compound, furanodienone (FDN), has been found to reduce inflammation and repair gut damage in IBD patients by ...

Inflammatory bowel disease is a chronic condition of unknown origin characterized by severe inflammation and mucosal destruction in the intestine. There are two main forms: Crohn s disease ...